Human Immunodeficiency Virus Type 1 (HIV-1) is the etiologic agent of AIDS in Central Africa, Europe, the United States and most countries worldwide. Recently a second group of immunodeficiency-associated retroviruses, designated HIV-2 was discovered in West Africa. HIV-2 is related to HIV-1, but differs from the prototype AIDS virus in its geographic distribution, its protein structure and antigenicity, as well as its nucleotide sequence and genomic organization. Also, while HIV-1 infection in populations worldwide has been associated with immune suppression and AIDS, infection with HIV-2 has not uniformly been associated with disease. In this project we propose to define determinants of HIV-2 pathogenicity in order to evaluate whether this virus, or certain strains of it, differ from HIV-1 in a biologically important way. To achieve this we will take two basic approaches: (i) we will study the function and significance of particular genes and regulatory sequences which are unique for HIV-2 and are not present in HIV-1. (ii) we will characterize on a molecular level naturally-occurring variants of HIV-2, which differ in their pathogenic potential. Specifically, we will a) define in vitro biological differences of HIV-2 variants using transfection-derived viral strains; b) identify those genes and/or regulatory regions that render certain strains of HIV-2 less cytopathic; c) compare and contrast envelope properties of naturally-occurring HIV-2 variants with respect to syncytia forming and cell killing abilities; d) determine the transcriptional map of HIV-2; e) elucidate the function of the novel HIV-2 X gene; and, f) express this gene for the development of specific reagents and X-ray crystallography. We expect these studies to yield important and new information regarding HIV-2 biology and pathobiology. We will perform the proposed experiments in direct collaboration with Dr. Casey Morrow (Project #4) and Dr. Richard Compans (Project #3), but our results will also be of importance and value to all other investigators of this program project who study HIV replication and pathogenesis.

Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Wilson, J E; Aulabaugh, A; Caligan, B et al. (1996) Human immunodeficiency virus type-1 reverse transcriptase. Contribution of Met-184 to binding of nucleoside 5'-triphosphate. J Biol Chem 271:13656-62
Dubay, J W; Dubay, S R; Shin, H J et al. (1995) Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J Virol 69:4675-82
Spies, C P; Ritter Jr, G D; Mulligan, M J et al. (1994) Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J Virol 68:585-91
Norris, J G; Tang, L P; Sparacio, S M et al. (1994) Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J Immunol 152:841-50
Clark, S J; Kelen, G D; Henrard, D R et al. (1994) Unsuspected primary human immunodeficiency virus type 1 infection in seronegative emergency department patients. J Infect Dis 170:194-7
Benveniste, E N (1994) Cytokine circuits in brain. Implications for AIDS dementia complex. Res Publ Assoc Res Nerv Ment Dis 72:71-88
Byrne, J A; Stankovic, A K; Cooper, M D (1994) A novel subpopulation of primed T cells in the human fetus. J Immunol 152:3098-106
Bray, M; Prasad, S; Dubay, J W et al. (1994) A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci U S A 91:1256-60
Borrow, P; Lewicki, H; Hahn, B H et al. (1994) Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68:6103-10
Piatak Jr, M; Saag, M S; Yang, L C et al. (1993) Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS 7 Suppl 2:S65-71

Showing the most recent 10 out of 58 publications